BrainKey is positioned around a consumer-facing brain-age metric derived from AI analysis of standard MRI scans, a concept that straddles wellness and clinical neuroimaging without fully committing to either regulatory pathway. The seed-stage company sits in a segment adjacent to clinical AI neuroimaging tools like Brainomix and BrainQuant but is differentiated by its direct-to-consumer orientation and lifestyle-health framing.